Literature DB >> 25307957

Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives.

Robert F Shearer1, Darren N Saunders.   

Abstract

The use of third-generation lentiviral vectors is now commonplace in most areas of basic biology. These systems provide a fast, efficient means for modulating gene expression, but experimental design needs to be carefully considered to minimize potential artefacts arising from off-target effects and other confounding factors. This review offers a starting point for those new to lentiviral-based vector systems, addressing the main issues involved with the use of lentiviral systems in vitro and outlines considerations which should be taken into account during experimental design. Factors such as selecting an appropriate system and controls, and practical titration of viral transduction are important considerations for experimental design. We also briefly describe some of the more recent advances in genome editing technology. TALENs and CRISPRs offer an alternative to lentivirus, providing endogenous gene editing with reduced off-target effects often at the expense of efficiency.
© 2014 Garvan Institute Genes to Cells published by Wiley Publishing Asia Pty Ltd and the Molecular Biology Society of Japan.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25307957     DOI: 10.1111/gtc.12183

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  26 in total

Review 1.  Transposase-mediated gene modulation in the placenta.

Authors:  Marlee Elston; Johann Urschitz
Journal:  Placenta       Date:  2017-07-29       Impact factor: 3.481

2.  Genome-wide In Vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity.

Authors:  Mary H Wertz; Mollie R Mitchem; S Sebastian Pineda; Lea J Hachigian; Hyeseung Lee; Vanessa Lau; Alex Powers; Ruth Kulicke; Gurrein K Madan; Medina Colic; Martine Therrien; Amanda Vernon; Victoria F Beja-Glasser; Mudra Hegde; Fan Gao; Manolis Kellis; Traver Hart; John G Doench; Myriam Heiman
Journal:  Neuron       Date:  2020-01-30       Impact factor: 17.173

3.  Replication Study: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.

Authors:  Mee Rie Sheen; Jennifer L Fields; Brian Northan; Judith Lacoste; Lay-Hong Ang; Steven Fiering
Journal:  Elife       Date:  2019-12-17       Impact factor: 8.140

4.  Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines.

Authors:  Stanley E Hooker; Leanne Woods-Burnham; K Sean Kimbro; Rick A Kittles; Madhavi Bathina; Stacy Lloyd; Priyatham Gorjala; Ranjana Mitra; Larisa Nonn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-20       Impact factor: 4.254

5.  The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line.

Authors:  Jing Zhang; Dongmei Wang; Na Hu; Qian Wang; Shanice Yu; Jun Wang
Journal:  Tumour Biol       Date:  2015-11-19

6.  A Method of Bone-Metastatic Tumor Progression Assessment in Mice Using Longitudinal Radiography.

Authors:  Matthew R Eber; Juan Miguel Jiménez-Andrade; Christopher M Peters; Yusuke Shiozawa
Journal:  Methods Mol Biol       Date:  2022

7.  Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Authors:  Fraser Aird; Irawati Kandela; Christine Mantis
Journal:  Elife       Date:  2017-01-19       Impact factor: 8.140

8.  Lentiviral vector-mediated co-overexpression of VEGF and Bcl-2 improves mesenchymal stem cell survival and enhances paracrine effects in vitro.

Authors:  Xiaobin Ni; Caiwen Ou; Jingbin Guo; Bei Liu; Jianwu Zhang; Zhiye Wu; Hekai Li; Minsheng Chen
Journal:  Int J Mol Med       Date:  2017-06-12       Impact factor: 4.101

9.  SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.

Authors:  N L E Harris; C Vennin; J R W Conway; K L Vine; M Pinese; M J Cowley; R F Shearer; M C Lucas; D Herrmann; A H Allam; M Pajic; J P Morton; A V Biankin; M Ranson; P Timpson; D N Saunders
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

10.  Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors.

Authors:  Konstantin Byrgazov; Chantal Blanche Lucini; Bettina Berkowitsch; Margit Koenig; Oskar A Haas; Gregor Hoermann; Peter Valent; Thomas Lion
Journal:  Oncotarget       Date:  2016-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.